Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine + fentanyl versus midazolam + ketamine for sedation during pediatric bone marrow biopsy
IRCT20160301026866N11Phase 3Completed
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- May 2020
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of dexmedetomidine, fentanyl, midazolam and ketamine in procedural sedation and analgesia (PSA) (2 arms), sponsored by Shahid Beheshti University of Medical Sciences. Primary endpoints: Sedation score, Mean arterial pressure and 1 more. Started May 2020; status: completed.
02
Drugs
dexmedetomidinefentanylmidazolamketamine
03
Conditions
procedural sedation and analgesia (PSA)
Beyond the preview
Go deeper on IRCT20160301026866N11.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20160301026866N11.